Viewing Study NCT05781633


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2025-12-26 @ 7:06 PM
Study NCT ID: NCT05781633
Status: UNKNOWN
Last Update Posted: 2023-03-23
First Post: 2023-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module